All data are based on the daily closing price as of December 5, 2025
c

Center Laboratories

4123.TWO
1.21 USD
0.01
+0.83%

Overview

Last close
1.21 usd
Market cap
889.54M usd
52 week high
1.74 usd
52 week low
0.93 usd
Target price
N/A usd

Valuation

P/E
17.5935
Forward P/E
N/A
Price/Sales
17.7506
Price/Book Value
1.4148
Enterprise Value
986.95M usd
EV/Revenue
19.7171
EV/EBITDA
12.1162

Key financials

Revenue TTM
50.06M usd
Gross Profit TTM
21.26M usd
EBITDA TTM
9.33M usd
Earnings per Share
0.07 usd
Dividend
0.02 usd
Total assets
846.79M usd
Net debt
128.61M usd

About

Center Laboratories, Inc., a pharmaceutical company, develops, manufactures, and sells pharmaceuticals in Taiwan and internationally. The company offers general medication pharmaceuticals comprising antipyretics and analgesics, bronchodilators, anti-inflammatory preparations, antihistamines, expectorants, narcotic antitussives and expectorants, gastrointestinal preparations, non-narcotic antitussives and expectorants, and other medicines. It also offers central nervous system medication consisting of treatments for cerebrovascular disease, dementia, depression, schizophrenia, epilepsy, and Parkinson's disease, as well as provides treatment for diabetes and pancreatic beta cells. In addition, the company engages in drug development, cell therapy, biotechnology, hydrogen energy, and dairy business. Center Laboratories, Inc. was founded in 1959 and is headquartered in Taipei City, Taiwan.
  • Symbol
    4123.TWO
  • Exchange
    TWO
  • Isin
    TW0004123005
  • Country
    Taiwan
  • Sector
    Healthcare
  • Industry
    Drug Manufacturers - Specialty & Generic
  • CEO
    Ms. Su-Chi Wang
  • Headquarter
    Taipei City
  • Web site
    https://www.centerlab.com.tw
Jakota Newsletter

Stay ahead in the JAKOTA stock markets with our roundup of vital insights

Icon scroll to top